Preoperative Investigations Guidelines
Preoperative investigations should not be ordered as a routine battery of tests for every patient. The decision should be based on the patient’s clinical condition, comorbidities, medications, age, and the type and extent of surgery.
Two commonly referenced guidelines are:
- Indian Society of Anaesthesiologists (ISA) Practice Guidelines for Preoperative Investigations — Indian Journal of Anaesthesia (IJA), 2022
- NICE Guideline NG45: Routine Preoperative Tests for Elective Surgery, 2016
Table of Contents
ToggleSURGERY CLASSIFICATION
Surgery is commonly classified according to its magnitude and expected physiological stress as:
Minor → Intermediate → Major
This classification helps determine the extent of preoperative assessment and investigations. It should be considered alongside ASA physical status, patient comorbidities, and urgency of surgery.
|
Category |
Typical characteristics |
Examples |
|
Minor surgery |
Limited tissue trauma, minimal blood loss, short duration, little physiological disturbance |
Cataract surgery, superficial skin procedures, minor breast procedures, diagnostic endoscopy |
|
Intermediate surgery |
Moderate tissue trauma, moderate physiological stress and/or blood loss |
Laparoscopic cholecystectomy, TURP, hysterectomy, joint arthroscopy, hernia repair |
|
Major surgery |
Extensive tissue trauma, significant blood loss/fluid shifts, prolonged duration or major physiological stress |
Major abdominal surgery, major vascular surgery, major orthopaedic surgery, oesophagectomy, major thoracic surgery |
NICE GUIDELINE
NICE recommends a selective, risk-based approach to preoperative investigations. The need for testing is determined mainly by the ASA physical status and grade of surgery (minor, intermediate or major), along with the patient’s history and clinical findings. Routine tests are avoided when they are unlikely to influence perioperative management. For example, CBC and renal function are recommended mainly with increasing ASA status and surgical severity, while LFT, coagulation tests and CXR are generally performed only when clinically indicated.
|
Investigation |
Minor surgery |
Intermediate surgery |
Major surgery |
|
CBC |
Not routine |
ASA III–IV |
All patients |
|
Renal function / Creatinine |
Not routine* |
ASA III–IV |
ASA II–IV |
|
ECG |
Not routine |
ASA III–IV |
ASA II–IV |
|
Coagulation profile |
Clinical indication |
Clinical indication |
Clinical indication |
|
LFT |
Clinical indication |
Clinical indication |
Clinical indication |
|
CXR |
Not routine |
Not routine |
Not routine |
|
Urinalysis |
Not routine |
Not routine |
Not routine |
|
Pregnancy test |
If possibility of pregnancy + result may affect management |
Same |
Same |
|
Sickle cell test |
Not routine |
Not routine |
Not routine |
* Renal function may be considered in selected patients at risk of perioperative AKI, including ASA III–IV undergoing minor surgery and ASA II undergoing intermediate surgery.
IJA GUIDELINE
The IJA/ISA guideline promotes a judicious, individualised approach to preoperative investigations rather than routine testing of every patient. Investigations should be guided by the type of surgery, ASA status, physiological condition, comorbidities, medications and clinical findings, with tests ordered when they are likely to influence perioperative management. It is specifically designed for ASA I–II patients undergoing elective surgery.
|
Investigation |
Minor surgery |
Intermediate surgery |
Major surgery |
|
CBC |
Suggested |
Suggested |
Suggested |
|
Serum creatinine / RFT |
Not suggested |
Suggested |
Suggested |
|
Serum Na⁺ / K⁺ |
Not suggested routinely |
Not suggested routinely |
Not suggested routinely |
|
LFT |
Not suggested |
Not suggested |
Suggested |
|
Coagulation profile (PT/INR, aPTT) |
Not suggested routinely |
Not suggested routinely |
Not suggested routinely |
|
Blood glucose – non-diabetic |
Not suggested routinely |
Not suggested routinely |
Not suggested routinely |
|
12-lead ECG |
≥45 yr* |
≥45 yr* |
All patients |
|
CXR |
Not suggested |
≥50 yr† |
≥50 yr† |
* ECG age criterion applies to non-cardiac patients undergoing minor/intermediate surgery.
† CXR age criterion applies to patients ≥50 years undergoing intermediate/major surgery.
Complete Blood Count (CBC)
CBC provides information about oxygen-carrying capacity, platelet count and the presence of leukocytosis or other haematological abnormalities.
|
Parameter |
Important points |
|
Haemoglobin |
Normal range in the reference: 13.5–17.5 g/dL in men and 12–15.5 g/dL in women. |
|
Haematocrit |
Hct <28% is associated with increased postoperative ischaemia and major adverse cardiac events in high-risk patients according to the reference. |
|
Platelets |
Normal: 150,000–450,000/µL. |
|
WBC |
Leukocytosis may indicate infection/inflammation. Pregnancy may produce physiological leukocytosis, with values reported up to 21,000/µL at term. |
Indications
CBC should be considered particularly for:
- Major surgery with significant blood-loss potential
- Suspected or known anaemia
- Haematological disease
- Malignancy
- Geriatric patients with suspected baseline anaemia
- Selected paediatric patients
- Situations where platelet count may influence the safety of regional/neuraxial anaesthesia
Anaesthetic relevance
CBC helps with:
Anaemia assessment → oxygen delivery assessment → transfusion planning
Platelet assessment → bleeding risk → suitability for neuraxial/regional techniques
The reference gives 100,000/µL as the usual platelet threshold below which regional blocks are avoided, while selected patients with low-grade HELLP may be considered at ≥70,000/µL.
2. Kidney Function Tests (KFT)
KFTs assess baseline renal function and help identify patients at increased risk of preoperative acute kidney injury.
Important parameters
|
Parameter |
Reference values / significance |
|
Creatinine |
0.8–1.3 mg/dL in men; 0.6–1.0 mg/dL in women |
|
BUN |
10–20 mg/dL |
|
Creatinine clearance / GFR |
Useful for assessing renal reserve, particularly in older patients |
Indications
Consider KFTs in:
- Known renal insufficiency
- Diabetes mellitus
- Hypertension
- Cardiovascular disease
- Geriatric patients
- Patients at risk of AKI
- Patients receiving potentially nephrotoxic medications
- Major surgery where significant fluid shifts are anticipated
Why potassium matters ???
Hypokalaemia
Can predispose to:
- Arrhythmias
- Muscle weakness
- Increased sensitivity to some drugs
Hyperkalaemia
Can cause:
- Conduction abnormalities
- Arrhythmias
- Potential cardiac arrest
Therefore a significant electrolyte abnormality may require correction before elective surgery, depending on severity and clinical context.
Important considerations
Renal function may be overestimated in elderly patients, because loss of muscle mass can mask a reduction in GFR despite a relatively normal serum creatinine.
The reference identifies:
- Creatinine >1.2 mg/dL → increased AKI risk
- Creatinine >2.0 mg/dL → significant cardiac risk factor
- BUN:Creatinine >15:1 → suggests prerenal dehydration/volume depletion
Pregnancy
Pregnancy is associated with increased renal blood flow and GFR. Therefore, serum creatinine is normally lower, approximately 0.5–0.6 mg/dL. A creatinine >1.0 mg/dL in pregnancy warrants evaluation.
Anaesthetic relevance
Renal assessment influences:
- Fluid management
- Electrolyte correction
- Drug dosing
- Choice and duration of neuromuscular blockers
- Risk assessment for postoperative AKI
3. Liver Function Tests (LFT)
Routine LFTs are not indicated in everyone.
LFTs are useful for assessing hepatocellular injury, hepatic synthetic function and nutritional status.
Consider LFTs in:
- Cirrhosis
- Active hepatitis
- Known liver disease
- Malnutrition
- Jaundice
- Passive hepatic congestion associated with severe right heart failure
- HELLP syndrome
- Planned major hepatic resection
Parameters may include:
- Bilirubin
- AST/ALT
- ALP
- Albumin
LFTs do not directly equal hepatic functional reserve.
For significant liver disease, also consider:
- INR
- Albumin
- Platelets
- Bilirubin
- Clinical portal hypertension
- Ascites
- Encephalopathy
- Renal function
Albumin
The reference lists normal albumin as 3.5–5.5 g/dL.
Albumin has a relatively long half-life of approximately 2–3 weeks. Therefore, it may remain normal during acute liver injury.
Albumin <2.5 g/dL suggests chronic liver disease, severe malnutrition or protein-losing states. Hypoalbuminaemia can increase the free fraction of highly protein-bound drugs.
Pseudocholinesterase
Pseudocholinesterase is synthesized in the liver and is responsible for hydrolysis of:
- Succinylcholine
- Ester local anaesthetics
Its level decreases during pregnancy and falls significantly in HELLP syndrome.
Anaesthetic relevance
Liver dysfunction may result in:
Altered drug metabolism + altered protein binding + coagulation abnormalities + prolonged drug action
Important parameters
|
Parameter |
Significance |
|
ALT / AST |
Markers of hepatocellular injury rather than direct measures of liver function |
|
Albumin |
Reflects chronic hepatic synthetic/nutritional status |
|
Bilirubin |
Reflects hepatic excretory function and bile handling; elevation may indicate hepatocellular dysfunction, cholestasis, or biliary obstruction |
|
Pseudocholinesterase |
Relevant to metabolism of succinylcholine and ester local anaesthetics |
4. Coagulation Profile
The coagulation profile evaluates secondary haemostasis and is particularly relevant when bleeding risk or neuraxial anaesthesia is a concern.
Important parameters
|
Test |
Reference value |
What it assesses |
|
PT |
11–14 sec |
Extrinsic/common pathway |
|
INR |
~1.0 |
Standardized assessment of PT |
|
aPTT |
25–35 sec |
Intrinsic/common pathway |
|
Fibrinogen |
200–400 mg/dL |
Fibrin formation/clot strength |
Indications
Consider coagulation testing in:
- Patients taking long-term anticoagulants
- Known or suspected liver disease
- Significant bleeding history
- Severe preeclampsia
- HELLP syndrome
- Patients in whom regional/neuraxial anaesthesia is being considered
PT / INR
PT is particularly sensitive to abnormalities in hepatic synthetic function because Factor VII has a short half-life.
The reference identifies PT prolongation >3 seconds / INR >1.5 as suggestive of severe hepatic synthetic dysfunction.
Fibrinogen
Normal fibrinogen is approximately 200–400 mg/dL.
In pregnancy, fibrinogen physiologically increases to approximately 400–500 mg/dL. A significant fall, particularly around delivery, can be an early warning sign of severe postpartum haemorrhage.
Anaesthetic relevance
Coagulation assessment helps determine:
Bleeding risk → need for correction/blood products → safety of neuraxial anaesthesia
5. 12-Lead ECG
A 12-lead ECG provides information regarding:
- Heart rate
- Rhythm
- Conduction
- Ischaemic changes
- Evidence of LV hypertrophy
Indications
Consider ECG in patients with:
- Known coronary artery disease
- Previous myocardial infarction
- Heart failure
- Hypertension
- Renal impairment
- Relevant cardiovascular symptoms
- Patients receiving drugs such as digoxin or diuretics
- Selected older/high-risk patients
Anaesthetic relevance
ECG may identify:
Silent ischaemia + Arrhythmias + Conduction abnormalities + LVH
These findings may alter the need for further cardiovascular evaluation, monitoring and perioperative planning.
6. Pulmonary Investigations
Spirometry / Pulmonary Function Tests
Important parameters include:
- FEV₁
- FVC
- DLCO
Indications
Consider in:
- Known COPD
- Known asthma when baseline assessment is useful
- Major thoracic surgery
- Planned lung resection
For lung resection, the reference highlights predicted postoperative FEV₁ and DLCO >40% as an important threshold.
Spirometry and chest radiography should not be used routinely in asymptomatic patients simply to predict postoperative pulmonary complications.
7. Chest X-ray
Chest radiography is not a routine investigation for every patient.
It may be considered when there is:
- Significant respiratory disease
- Significant cardiac disease
- Relevant respiratory symptoms
- Suspected pulmonary pathology
- A specific surgical indication
Potential findings include:
- Hyperinflation
- Cardiomegaly
- Pulmonary pathology
8. Arterial Blood Gas (ABG)
ABG provides information about:
- pH
- PaO₂
- PaCO₂
- HCO₃⁻
Indications
Consider ABG in:
- Severe asthma/COPD undergoing major thoracic or abdominal surgery
- Significant respiratory disease with concern regarding gas exchange
- Kidney failure with tachypnoea
- Suspected significant acid-base disturbance
Anaesthetic relevance
ABG establishes a baseline for:
Oxygenation + Ventilation + Acid-base status
9. Echocardiography
This is not a routine preoperative test.
Consider when there is clinical suspicion of significant structural/functional heart disease.
Examples:
- Suspected heart failure
Symptoms:
- Dyspnoea
- Orthopnoea
- PND
- Peripheral oedema
– Suspected significant valvular disease
For example:
- Severe AS
- Significant MR
– Unexplained dyspnoea
Known cardiac disease with a clinically important change
Why does echo matter to the anaesthesiologist?
It gives information about:
- LV systolic function
- Diastolic function
- Valve pathology
- Chamber size
- Pulmonary pressures
- RV function
This can fundamentally change:
Anaesthetic technique + monitoring + haemodynamic goals.
|
Investigation |
When is it indicated? |
What are we looking for? |
Anaesthetic relevance |
|
CBC / Hemogram |
Suspected or known anaemia, bleeding history, haematological disease, malignancy, major surgery or significant expected blood loss |
Haemoglobin, platelet count, leukocyte abnormalities |
Anaemia affects oxygen delivery; thrombocytopenia may increase bleeding risk and influence suitability for neuraxial procedures |
|
KFT + Electrolytes |
Renal disease, diabetes, hypertension, cardiovascular disease, suspected renal impairment, elderly patients, major surgery or risk of fluid/electrolyte disturbance |
Creatinine, eGFR, urea, Na⁺, K⁺ and other relevant electrolytes |
Guides fluid therapy, electrolyte correction and drug selection/dosing; renal dysfunction alters clearance of several anaesthetic drugs |
|
LFT |
Known/suspected liver disease, hepatitis, cirrhosis, jaundice, malnutrition, right heart failure with hepatic congestion, or relevant pregnancy-related disease such as HELLP |
Hepatocellular injury and hepatic synthetic/nutritional status |
Liver dysfunction may alter drug metabolism, protein binding and coagulation |
|
Coagulation profile |
Bleeding history, liver disease, anticoagulant therapy, severe pre-eclampsia, or when neuraxial/regional anaesthesia is being considered |
PT/INR, aPTT, fibrinogen when indicated |
Helps assess coagulation abnormalities and bleeding risk; particularly relevant before neuraxial procedures |
|
12-lead ECG |
Known/suspected CAD, previous MI, heart failure, hypertension, renal impairment, relevant symptoms, or selected patients with significant comorbidity/age |
Rate, rhythm, conduction, ischaemic changes, LVH |
Identifies arrhythmias, conduction abnormalities and evidence of cardiac disease that may alter perioperative management |
|
Chest X-ray |
Not routine. Consider when there is significant respiratory/cardiac disease, symptoms, or a specific surgical indication |
Cardiomegaly, pulmonary pathology and other thoracic abnormalities |
Helps assess significant cardiopulmonary pathology when clinically indicated |
|
Pulmonary function tests |
Known COPD/asthma when baseline assessment is useful; particularly relevant before lung resection or selected major thoracic surgery |
FEV₁, FVC, DLCO |
Assesses pulmonary reserve and helps determine suitability for lung resection; not routinely required in asymptomatic patients |
|
ABG |
Severe asthma/COPD undergoing major thoracic or abdominal surgery, significant respiratory disease, hypoxaemia/hypercapnia, or renal failure with tachypnoea |
PaO₂, PaCO₂, pH, HCO₃⁻ |
Establishes baseline oxygenation, ventilation and acid–base status |
|
Blood glucose |
Known diabetes, suspected dysglycaemia, or patients receiving glucose-lowering therapy |
Current glucose level |
Allows perioperative glycaemic management and identification of significant hypo/hyperglycaemia |
|
HbA1c |
Known diabetes when recent glycaemic control is unavailable or when optimization is required |
Longer-term glycaemic control |
Helps assess adequacy of diabetic control and need for optimization |
|
Blood grouping / Type & screen / Crossmatch |
Surgery with significant anticipated blood loss, anaemia, major surgery or high transfusion risk |
ABO/Rh group and compatible blood availability |
Ensures blood/components can be made available when significant haemorrhage is anticipated |
|
Pregnancy test |
When pregnancy is possible and the result could alter anaesthetic, surgical, imaging or medication management |
Pregnancy status |
Pregnancy significantly alters airway, respiratory, cardiovascular and aspiration considerations |
|
Echocardiography |
Suspected/significant valvular disease, heart failure, unexplained dyspnoea or other clinical indication |
Ventricular function, valves and cardiac structure |
Helps assess cardiac reserve and guide perioperative haemodynamic planning |
|
Urinalysis |
Urinary symptoms, suspected UTI or selected procedures where the result will affect management |
Urinary infection/proteinuria/other abnormalities |
Identifies clinically relevant urinary pathology when indicated |
|
VM (Viral Markers) |
According to institutional policy, occupational-health requirements, relevant clinical history, suspected or known viral infection, or when the result will affect perioperative planning |
Relevant viral infection markers, such as hepatitis B, hepatitis C and HIV, as clinically or institutionally indicated |
Supports infection-control planning, appropriate precautions and perioperative management; a positive result should not delay urgent surgery |
What is truly “routine”?
There is no universal routine investigation panel.
For a young, healthy, asymptomatic patient undergoing minor surgery, extensive laboratory and imaging investigations may not be required.
For a patient with significant comorbidities or major surgery, investigations become more extensive and should be targeted to the clinical problem.
Every investigation should have a reason. Ask: “If this result is abnormal, will it change my management?”
References
- Miller RD, Cohen NH, Eriksson LI, et al. Miller’s Anesthesia. Elsevier.
— Perioperative evaluation, preoperative testing, and anesthetic risk assessment. - Butterworth JF, Mackey DC, Wasnick JD. Morgan & Mikhail’s Clinical Anesthesiology. McGraw-Hill.
— Preoperative evaluation and selection/interpretation of laboratory investigations. - Barash PG, Cullen BF, Stoelting RK, et al. Clinical Anesthesia. Wolters Kluwer.
— Preoperative assessment and perioperative laboratory testing. - American Society of Anesthesiologists (ASA). Practice Advisory for Preanesthesia Evaluation.
— Guidance on appropriate preanesthetic assessment and investigations. - National Institute for Health and Care Excellence (NICE). Routine Preoperative Tests for Elective Surgery (NG45).
— Evidence-based recommendations on when CBC, coagulation studies, renal function, ECG, chest X-ray and other investigations should be performed.
6. Goneppanavar U et al. Preoperative Investigations: Practice Guidelines from the Indian Society of Anaesthesiologists. Indian J Anaesth. 2022;66(5):319–343, Table 6, Recommendations 1–10.
